RetaCagri (Retatrutide + Cagrilintide)
A proprietary co-formulation combining a triple GIP/GLP-1/GCGR agonist with a long-acting amylin analogue. Utilized to investigate profound, multi-receptor metabolic signaling and energy homeostasis.
$186.00
Size / Spec: 10mg / vial
Format: Lyophilized Powder
CAS Number: N/A (Blend)
Chemical Formula: N/A (Blend)
Molecular Wt.: N/A (Blend)
Out of stock
Storage Instructions
In lyophilized form, store at -20°C to 4°C. Keep away from light. If reconstituted, refrigerate.
Mandatory Disclaimer
For Research Use Only. Not for human or animal consumption.
Money Back Guarantee
Satisfaction Guarantee
Easy Returns
Secure Ordering
Product Features
- Quad-receptor targeting (GIP/GLP-1/GCGR/Amylin)
- Advanced blend for comprehensive metabolic research
- Highly stable co-lyophilized formulation
- Suitable for in vitro preclinical research
- Greater than 99% pure HPLC
Products you may like
Semaglutide
A synthetic peptide engineered as a selective GLP-1 receptor agonist. Utilized to investigate incretin pathway activation, delayed gastric emptying models,…
AOD-9604:
A modified C-terminal fragment of human growth hormone (hGH 177-191). Utilized to investigate localized lipolytic activity and metabolic signaling without…
Cagrilintide
A synthetic, long-acting amylin analogue. Utilized to investigate calcitonin and amylin receptor agonism, evaluating its role in satiety signaling and…
Tirzepatide
A synthetic peptide engineered as a dual GIP and GLP-1 receptor agonist. Utilized to investigate synergistic incretin receptor binding and…